Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (381-390 of 471) with videos related to

Pageof 48
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Implications of MYC Rearrangements in Newly Diagnosed Multiple MyelomaNadine Abdallah, Linda B Baughn, S Vincent Rajkumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2019
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction TherapyBharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, et al.
Leukemia|January 25, 2019
Comparative analysis of staging systems in AL amyloidosisEli Muchtar, Terry M Therneau, Dirk R Larson, et al.
Mayo Clinic Proceedings|March 6, 2021
Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent TherapyBharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, et al.
American Journal of Hematology|August 12, 2017
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trialsArjun Lakshman, Jithma P Abeykoon, Shaji K Kumar, et al.
Kidney International|July 27, 2020
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosisCihan Heybeli, Andrew Bentall, Jiqiu Wen, et al.
Blood Cancer Journal|August 13, 2020
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment responseNadine Abdallah, S Vincent Rajkumar, Patricia Greipp, et al.
Blood Cancer Journal|August 12, 2024
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and managementArushi Khurana, Allison C Rosenthal, Razan Mohty, et al.
American Journal of Hematology|April 5, 2019
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapyMarcella A Tschautscher, Dragan Jevremovic, Vincent Rajkumar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteriaEli Muchtar, Angela Dispenzieri, Nelson Leung, et al.
Pageof 48

Showing results (381-390 of 471) with videos related to

Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Implications of MYC Rearrangements in Newly Diagnosed Multiple MyelomaNadine Abdallah, Linda B Baughn, S Vincent Rajkumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2019
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction TherapyBharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, et al.
Leukemia|January 25, 2019
Comparative analysis of staging systems in AL amyloidosisEli Muchtar, Terry M Therneau, Dirk R Larson, et al.
Mayo Clinic Proceedings|March 6, 2021
Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent TherapyBharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, et al.
American Journal of Hematology|August 12, 2017
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trialsArjun Lakshman, Jithma P Abeykoon, Shaji K Kumar, et al.
Kidney International|July 27, 2020
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosisCihan Heybeli, Andrew Bentall, Jiqiu Wen, et al.
Blood Cancer Journal|August 13, 2020
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment responseNadine Abdallah, S Vincent Rajkumar, Patricia Greipp, et al.
Blood Cancer Journal|August 12, 2024
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and managementArushi Khurana, Allison C Rosenthal, Razan Mohty, et al.
American Journal of Hematology|April 5, 2019
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapyMarcella A Tschautscher, Dragan Jevremovic, Vincent Rajkumar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteriaEli Muchtar, Angela Dispenzieri, Nelson Leung, et al.
Pageof 48